Evaluation of TachoSil® Application on a Colorectal Anastomosis (TC-029-IM)

PHASE2CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

June 30, 2008

Primary Completion Date

June 30, 2009

Study Completion Date

July 31, 2010

Conditions
Colorectal Anastomosis
Interventions
DRUG

TachoSil®

"Sterile, ready-to-use, absorbable sponge for intra-operative topical application. It consists of an equine collagen sponge coated with the fibrin glue components human fibrinogen and human thrombin.~Surgery was performed according to the hospitals' local standards. When the anastomosis was performed, all enrolled subjects had TachoSil® applied around the anastomotic line. TachoSil® was therefore an add-on therapy."

Trial Locations (3)

Unknown

Investigational site, Berlin

Investigational site, Utrecht

Investigational site, Dartford

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Nycomed

INDUSTRY

NCT00713661 - Evaluation of TachoSil® Application on a Colorectal Anastomosis (TC-029-IM) | Biotech Hunter | Biotech Hunter